drug
(benzoyl peroxide + tretinoin)
Marketedupdated 3mo agoby Mayne Pharma USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 3, 2028
~1.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (13)
- May 23, 2041formulationUS 12133919
- May 23, 2041formulationUS 12257348
- May 23, 2041formulationUS 12491163
- Dec 27, 2040method-of-use (U-3987)US 12295935
- Jul 12, 2038method-of-use (U-3194)US 10420743
- Jul 12, 2038formulationUS 12357602
- Jun 29, 2032formulationUS 12053546
- Dec 30, 2030formulationUS 106538994.4y
- Dec 30, 2030formulationUS 110718784.4y
- Dec 30, 2030formulationUS 120706294.4y
- Aug 8, 2028formulationUS 98681032.0y
- Feb 3, 2028formulationUS 121569461.5y
- Feb 3, 2028formulationUS 86175801.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 51m ago
Found something off?
comments(0)
5-min edit window · permanent after that